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The paramyxovirus simian virus 5 (SV5) has seven genes but encodes eight known viral proteins. The V/P gene is transcribed into two
mRNA species: V mRNA from a faithful transcription of the gene and P mRNA from transcription with addition of two G residues at a
specific site of the gene. V, a 222-amino acid (AA) residue protein, and P, a 392 AA residue protein, share an identical N-terminus domain of
164 amino acid residues. P is essential for SV5 RNA replication and transcription. Whereas it is known that V plays important roles in virus
pathogenesis, the role of V in SV5 replication and transcription is not clear. A mini-genome system, free of vaccinia virus gene expression
system, consisting of plasmids expressing NP, P, and L, as well as a plasmid encoding a reporter gene, chloramphenicol acetyltransferase
(CAT) flanked by SV5 trailer and leader sequences under control of a bacteriophage T7 RNA polymerase promoter, has been established to
examine the role of V in SV5 RNA transcription and replication. Addition of V-expressing plasmid in the mini-genome system caused
inhibition of the reporter gene expression, suggesting that V plays a role in regulating SV5 gene expression. By examining the amount of
encapsidated viral RNA genome using reverse transcription with primer annealing to viral anti-genome RNA and PCR, it was found that
expression of V reduced the amount of viral RNA genome in the mini-genome system, suggesting that V inhibits viral RNA replication. To
examine whether the V protein inhibits viral RNA transcription as well, a mini-genome system with a defective anti-genome promoter (AGP)
such that a reporter gene (luciferase, Luc) expression is only derived from transcription of newly produced mini-genome and not from de novo
replicated viral genome due to the defect in replication element has been utilized. The V protein inhibited luciferase expression from the mini-
genome with a defective AGP, suggesting V inhibits SV5 transcription. Thus, SV5 V inhibits both SV5 RNA replication and transcription.
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Simian virus 5 (SV5) is a prototypical member of the
Rubulavirus genus of the family Paramyxoviridae, which
includes many well known human and animal pathogens
such as mumps virus, human parainfluenza virus type 2
(HPIV2) and type 4 (HPIV4), Newcastle disease virus
(NDV), Sendai virus, HPIV3, measles virus, canine dis-0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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E-mail address: bxh40@psu.edu (B. He).temper virus, rinderpest virus, and respiratory syncytial (RS)
virus, as well as important emerging viruses such as Hendra
virus and Nipah virus (Lamb and Kolakofsky, 2001).
Although SV5 was originally isolated from cultured primary
monkey cells its natural host is the dog in which it causes
kennel cough (McCandlish et al., 1978). SV5 is believed to
infect humans (Cohn et al., 1996) and isolates have been
obtained from human sources, but no known symptoms or
diseases in humans have been associated with SV5 (Hsiung et
al., 1965).
SV5’s negative-stranded RNA genome is 15264 nucleo-
tides long and has seven genes but encodes eight known viral
proteins (Lamb and Kolakofsky, 2001). Nucleocapsid protein
(NP), phosphoprotein (P), and large RNA polymerase (L)05) 270 – 280
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viral RNA genome. The functional template for transcription
and replication of SV5, like other non-segmented negative
sense RNA viruses, is the nucleocapsid (NC) which consists
of nucleocapsid protein (NP)-encapsidated RNA (Lamb and
Kolakofsky, 2001). The viral RNA-dependent RNA poly-
merase (vRNAP) consists of two proteins, P and L. The P–L
complex transcribes the nucleocapsid protein (NP)-encapsi-
dated RNA into 5Vcapped and 3Vpolyadenylated mRNAs and
replicates genome RNA in cytoplasm (Emerson and Yu,
1975). The V protein plays important roles in viral patho-
genesis (details will be discussed below). The fusion (F)
protein, a glycoprotein, mediates virus entry into cells by
promoting both cell-to-cell and virus-to-cell fusion in a pH-
independent manner (Paterson et al., 1984, 1985). The
hemagglutinin–neuraminidase (HN), another viral glycopro-
tein, is also involved in virus entry and release from the host
cells (Paterson et al., 1985; Schmitt et al., 1999, 2002). The
matrix (M) protein plays an important role in virus egress
(Schmitt et al., 1999, 2002). The small hydrophobic (SH)
protein is a 44-AA residue hydrophobic integral membrane
protein and plays a role in blocking a tumor necrosis factor
(TNF)-a-mediated extrinsic apoptotic pathway (He et al.,
1998, 2001; Lin et al., 2003).
The V/P gene of SV5 is transcribed into the V mRNA by
faithfully transcribing the gene and the P mRNA through a
process of pseudo-templated addition of nucleotides, com-
monly called ‘‘RNA editing’’ (Thomas et al., 1988). It is
thought that during transcription the viral RNA polymerase
complex recognizes a specific RNA sequence in the V/P
gene and inserts two non-templated G residues at the site to
generate the P mRNA. As a result, the V/P gene is
transcribed into two mRNAs and translated into two
proteins, which share identical N-termini but different C-
termini. Insertion of the G residues occurs about 50% of the
time, resulting in about an equal amount of V and P mRNA
being produced. The process of inserting non-templated
residues occurs for almost all viruses in the subfamily
Paramyxovirinae (Lamb and Kolakofsky, 2001). Interest-
ingly, only in Rubulaviruses is the V mRNA faithfully
transcribed from the genome RNA; for the Respiroviruses
and the Morbilliviruses the P mRNA is faithfully tran-
scribed from the genome RNA and the V mRNA is the
result of the additional pseudo-templated G nucleotide(s)
(Jacques and Kolakofsky, 1991). Although the V proteins
are produced differently in the Paramyxovirinae, the
sequences of the C-terminal domain of the V proteins are
highly conserved among the paramyxoviruses.
The V protein of SV5 is a multifunctional protein and
plays important roles in viral pathogenesis. The V protein is
essential to counter host interferon action. The V protein
blocks interferon (IFN) signaling in infected cells by causing
degradation of STAT1 protein in human cells (Didcock et al.,
1999) and inhibits interferon-h production by sequestering
IRF-3 in the cytoplasm (He et al., 2002; Poole et al., 2002). V
interacts with MDA-5, an IFN-inducible RNA helicase,which plays an important role in inhibiting IFN-h promoter
(Andrejeva et al., 2004). The V protein C-terminal domain
contains seven cysteine residues, which are very well
conserved among all paramyxoviruses, resembles a zinc
finger domain, and binds atomic zinc (Liston and Briedis,
1994; Paterson et al., 1995; Steward et al., 1995; Thomas et
al., 1988). SV5 lacking the C-terminus of the V protein
(rSV5VDC) causes apoptosis in infected cells and the V
protein can block cell death induced by rSV5VDC, suggest-
ing V can inhibit apoptotic signal pathways (Sun et al., 2004).
The SV5 V protein, via its cysteine-rich C-terminus, interacts
with a cellular protein (DDB1), the 127-kDa subunit of the
damage-specific DNA-binding protein (DDB) that is
involved in damaged DNA repair. Deletion of the C-terminus
from the V protein interrupts the interaction (Lin and Lamb,
2000). Overexpression of the SV5 V protein in cells slows
down the cell cycle (Lin and Lamb, 2000). Co-expression of
DDB1 can partially restore the changes in cell cycle caused
by V expression (Lin and Lamb, 2000). V, DDB1, Cul4A,
STAT1, and STAT2 form a complex, which is essential for V-
mediated STAT1 degradation and V has an E3 ubiquitin
ligase activity (Ulane and Horvath, 2002).
The role of SV5 V in viral RNA transcription and
replication is not clear. It is known that the V protein of SV5
interacts with soluble NP (Randall and Bermingham, 1996)
and the N-terminal domain of V binds RNA through a basic
region (Lin et al., 1997b). Since V shares an identical N-
terminus of 164 AAwith P, which is essential for SV5 RNA
transcription and replication, it is thought that V may play a
role in SV5 RNA transcription and replication. To inves-
tigate this putative role played by V in SV5 RNA
transcription and replication, a mini-genome system, free
of vaccinia virus (VV) gene expression, consisting of
plasmids expressing NP, P, and L, as well as a plasmid
encoding a reporter gene, CAT flanked by SV5 trailer and
leader sequences under control of a bacteriophage T7 RNA
polymerase promoter has been established in this work. In
addition, a mini-genome system with a defective anti-
genome promoter (AGP) that cannot be replicated but still
can be transcribed has been constructed. Using the mini-
genome systems, the role of SV5 V in transcription and
replication has been investigated.Results
Establishing a mini-genome system free of vaccinia virus
To study the role of V in viral transcription and
replication, it is desirable to have a mini-genome system
that is free of vaccinia virus. We constructed a mini-genome
plasmid, containing the SV5 leader (Le), trailer (Tr) ,and a
reporter gene, CAT (Fig. 1A), under the control of a T7
RNAP promoter. Transcription from the T7 promoter results
in a negative strand mini-genome. In the presence of NP, P,
and L, this template is used for transcription to give rise to
Fig. 1. Establishment of a mini-genome system free of vaccinia virus. (A) Schematic of the mini-genome system. Plasmid pMG-CAT contains an SV5 mini-
genome flanked at one end by a bacteriophage T7 RNA polymerase (T7 RNAP) promoter (PT7) and at the other end by a hepatitis delta virus ribozyme
(Ribozyme) and T7 transcriptional terminator (T7–Tf). T7 RNA transcripts can be synthesized under the control of the T7 promoter to generate viral negative
sense SV5 RNA. pMG-CAT contains three extra G residues after the T7 RNAP promoter and prior to the SV5 trailer sequence (Tr) in order to increase T7
RNAP transcription efficiency. The exact leader sequence (Le) is generated by cleavage with hepatitis delta virus ribozyme. The plasmids pCAGGS-L,
pCAGGS-P, and pCAGGS-NP were used to express L, P, and NP in BSR T7 cells, a cell line that constitutively express T7 RNAP. CAT gene expression can be
generated from transcription of primary T7 transcript and vRNA sense genome through viral RNA replication. 5VNP: 5Vsequence of NP gene; 3VL: 3Vsequence
of L gene. (B) Reporter gene CAT expression from the mini-genome system. Plasmids encoding NP, P, L, and pMG-CAT at various combinations were
transfected into BSR T7 cells in 6-well plates in triplicates and relative CAT activities were measured as described in Materials and methods. All transfections
included plasmid pMG-CAT. pCAGGS-GFP was added to equalize amount of DNA used in transfection. Error bars are standard deviation of mean (SEM). A
similar mini-genome plasmid containing Renilla luciferase (Rluc) (pMG-Rluc) in the place of the CAT gene was also constructed.
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as used as template for replication. Previously, optimal
ratios and amounts of NP, P, and L expression plasmids
were determined to rescue infectious SV5 from cDNA.
Similar ratios and amounts of NP, P, and L plasmids were
used in the mini-genome system. However, due to variations
among different DNA preparations, optimal amount of
plasmids were re-calibrated with each DNA preparation.
When plasmids encoding P, NP, and L plus the mini-genome
plasmid (pMG-CAT) were transfected into BSR T7 cells, a
derivative of BHK cells that expresses T7 RNAP con-
stitutively, CAT activity was detected in cells transfectedwith all the plasmids but not in cells lacking any one of the
plasmids (Fig. 1B). That CAT expression depends on all
components of SV5 RNA synthesis machinery: NP, P, L,
and viral genome indicates the VV-free mini-genome
system works as expected. A similar system using Renilla
luciferase as a reporter gene has also been established (data
not shown).
Inhibition of CAT expression by V
To examine the role of V in SV5 RNA replication and
transcription, V-expressing plasmid was co-transfected with
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activities of transfected cells were examined. In the presence
of V-expressing plasmid, CAT activity was reduced and this
reduction was dosage dependent: more V-expressing plas-
mid, less CAT activity; whereas expression of GFP had no
effect on CAT activity (Fig. 2A), suggesting it is expression
of V, not expression of other protein such as GFP, that
caused reduction of CAT activity. To examine whether
inhibition of the reporter gene expression by V is due to
abnormally high levels of the V protein expression, the
relative expression levels of V to P in the mini-genome
system were compared to the level of V in SV5-infected
cells. It is known that V expression level is about the same
as P expression level in SV5-infected cells. Shown in Fig.
2B, the ratio of V to P is similar in both SV5-infected cells
and in the mini-genome-transfected cells, indicating inhib-
ition of the reporter gene expression in the mini-genome
system by V is within the normal relative V expression level
using P as a reference. Also shown in Fig. 2B is that
increased amount of plasmid encoding V transfected into
the cells resulted in increased amount of the V protein
expressed in the cells. Although V is not known to affect
expression level of L, effects of V on SV5 L expression in
the mini-genome system were examined using RT-PCR.
Total RNA from transfected cells were purified and treated
with DNase to remove possible contaminating plasmid
DNA. Polyadenylated mRNA were purified from the total
RNA and used for RT-PCR reactions. Whereas PCR
reactions using purified mRNA did not produce any
detectable product indicated that there was no contamination
from plasmid DNA, RT-PCR reactions using mRNA from
the transfected cells with high concentrations of the V-
expressing plasmid or without the V-expressing plasmid
generated comparable amounts of actin and L indicated that
V had no effect on the expression of L mRNA in the mini-
genome system (Fig. 2C).
V reduced amounts of viral genome in the mini-genome
system
The result that V inhibited the reporter gene expression in
the SV5 mini-genome system suggests that V plays a role in
regulating SV5 gene expression. To investigate the mecha-
nism of the inhibition, effects of V on the amount of viral
RNA genome in the mini-genome system were examined. It
is possible that V inhibits SV5 RNA replication and
reduction of viral genome RNA results in less mRNA
being made. To test the hypothesis directly, amounts of viral
RNA genome in different transfection combinations were
compared using RT-PCR. Viral RNA genomes were reverse
transcribed into cDNA using a primer annealing to anti-
genome sense RNA. Staged PCR reactions with progres-
sively increasing numbers of cycles, which quantify the
amount of DNA more accurately than a single-stage,
endpoint PCR reaction, were carried out. Whereas no
PCR products were observed from RNA template alone,larger amounts of PCR products were observed from the
cells transfected with the mini-genome system without V
than the cells transfected with the mini-genome system with
V at all stages when PCR product was detectable.
Quantification of the intensities of the bands in Fig. 3
indicated that there was about 90% reduction of the
intensities of the band in the lane with V compared to the
lane without V (data not shown). The results indicate that
there were more viral RNA genomes (anti-genome sense) in
the cells transfected with the mini-genome system without V
than the cells transfected with the mini-genome system with
V, suggesting that V inhibits viral RNA replication (Fig. 3).
V inhibited luciferase expression from the mini-genome
system with a defective anti-genome promoter
The result shown in Fig. 3 indicates V can inhibit
reporter gene expression in the mini-genome system by
reducing the amount of viral genome. It does not rule out the
possibility that V can also inhibit viral RNA transcription.
To investigate whether V inhibits viral RNA transcription, a
mini-genome system in which a luciferase reporter gene
expression is only derived from SV5 transcription has been
established. It is known that anti-genome promoter is
essential for replication of SV5 RNA from anti-genome
sense to genome sense but not for transcription from viral
genome promoter. Thus, mutations in the anti-genome
promoter can affect SV5 replication without affecting SV5
transcription. A plasmid containing a mutant anti-genome
promoter (AGP), a 6-nucleotide deletion in the CRI region
of AGP (Keller and Parks, 2003), otherwise identical to the
mini-genome plasmid, was generated (Fig. 4A). To test
whether the AGP plasmid can drive expression of the
luciferase reporter gene, different amounts of the plasmid
were transfected into cells with plasmids expressing NP, P,
and L and higher than background levels of luciferase
expression was observed in the cells transfected with NP, P,
and L plus pMG-AGP-Rluc (data not shown). To investigate
whether V can inhibit SV5 transcription, V-expressing
plasmid was included in the transfection with the mutant
AGP mini-genome system. As expected, the reporter gene
expression from the system with a mutant AGP is lower
than the system with wild-type AGP. It was found that the V
protein inhibited luciferase expression in the transfected
cells close to the level of background, suggesting V inhibits
SV5 RNA transcription (Fig. 4B). Also shown in Fig. 4B is
that increased amount of plasmid encoding V transfected
into the cells resulted in increased amount of the V protein
expression in the cells.
The overexpression of P is sufficient to inhibit luciferase
expression
It is known that P is essential for SV5 RNA synthesis.
Because P has the same N-terminus as V and V inhibits SV5
RNA synthesis, the effect of overexpressing P on the
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Fig. 3. Effect of Von SV5 RNA replication. BSR T7 cells were transfected as described before. NP-encapsidated RNAs were purified as described in Materials
and methods. Primer that anneals to positive sense vRNA at SV5 trailer sequence was used in reverse transcription, followed by PCR reactions using primer
pairs that cover C-terminus of the CAT gene and SV5 trailer sequence. Expected size of PCR product is about 250 base pairs (bp). Ethidium bromide staining
of products from RT-PCR reactions is shown. Left panel, purified RNAs were used directly for PCR without reverse transcription reaction. Right panel,
products from staged RT-PCR reactions are shown. C: control, cells transfected with P, NP, and L but without pMG-CAT; V: cells transfected with P, L, and
NP plasmids as well as pMG-CAT; +V: cells transfected with P, L, and NP, pMG-CAT plus V-expressing plasmid. DNA ladder: 100 bp DNA size makers. The
bottom fragment size is 200 bp.
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was observed that luciferase expression was reduced when P
was overexpressed. Expression levels of P were detected
using immunoblot (Fig. 5).Discussion
Mini-genome systems of negative strand RNA virus
utilizing vaccinia virus (VV) gene expression system have
been very useful to elucidate mechanisms of many
important aspects of virus replication and transcription.
High levels of protein expression by the VV gene
expression have enabled many important observations of
paramyxovirus RNA synthesis and have provided a good
system to understand mechanisms of viral RNA synthesis.
However, because vaccinia virus can cause homologous
DNA recombination among transfected plasmid DNA
(Evans et al., 1988) and V- and P-expressing plasmids are
very similar, it is highly desirable to have a mini-genome
system free of interference from vaccinia virus in general
and to study functions of V and P of SV5 in particular.
Previously, it was shown that infectious SV5 can be
recovered without using the vaccinia virus gene expression
system, suggesting it is possible to have a mini-genomeFig. 2. Inhibition of reporter gene expression from the mini-genome system by V. B
of the cells were measured as described in Materials and methods. All transfection
pCAGGS-L (2 Ag), pCAGGS-NP (1.6 Mg), and pCAGGS-P (0.6 Ag) except one s
Increasing amounts of V-expressing plasmid pCAGGS-V (0, 0.17, 0.5, 1, and 1
amount of DNA used in transfection. Error bars are standard deviation of mean (S
cells in 6-well plates were mock infected or were infected with rSV5 at an M.O.I.
CAT reporter gene as described in Materials and methods. At 18 h post-infection, o
The cells were lysed and immunoprecipitated using anti-NP (NP214) and anti-V/P (
PAGE using a 15% polyacrylamide gel. The ratio of V to P in infected and tran
Expression of L. The cells were transfected as in panels A and B. The transfected c
actin genes were used for RT-PCR. Expected sizes of L and actin are about 130 b
DNA size marker.system for SV5 without using vaccinia virus (He et al.,
2002; Waning et al., 2002). However, it was not clear
whether the system would be sensitive enough for a mini-
genome system. In rescuing of infectious virus, efficiency of
the system is not as critical since virus can replicate itself
once first infectious virus is generated. It is estimated, in the
best-case scenario, that rescuing of infectious virus occurs
less than a hundred times per transfection. Utilizing the
expression plasmids used for rescuing SV5 virus, a mini-
genome of SV5 containing a reporter gene CAT under
control of SV5 replication and transcription elements has
been established, free of vaccinia virus infection, in this
work. With the VV-free system, it is thus possible to
examine the involvement of the V protein in SV5 RNA
synthesis. In addition, the system will be useful to study
SV5 and host interactions. It is known that SV5 infection
can activate NF-nB (Lin et al., 2003). However, the
mechanism is not clear. It is possible that individual viral
protein or viral RNA synthesis process can activate NF-nB.
The VV-free mini-genome system established in this work is
well suited to elucidate relationship between viral RNA
synthesis and host responses free of complications of
vaccinia virus infection.
Because the V protein shares the N-terminus with the P
protein, involvement of SV5 V in viral RNA synthesis hasSRT7 cells in 6-well plates in triplicates were transfected and CAT activities
s include equal amounts of total DNA including plasmid pMG-CAT (1 Ag),
et of cells were transfected without pCAGGS-L as negative control (No L).
.5 Ag) were used in different cells. pCAGGS-GFP was added to equalize
EM). (A) Inhibition of CAT expression by V; (B) expression of V. BSR T7
of 3 pfu/cell or were transfected with plasmids expressing SV5 NP, P, and a
r at 42 h post-transfection, cells were metabolically labeled with 35S-Promix.
Pk) antibody as described previously. Polypeptides were analyzed by SDS–
sfected cells was determined using ImageQuant 5.1 (data not shown). (C)
ells were lysed and total mRNAs were purified. Primers annealing to L and
p and 410 bp, respectively. RT, reverse transcriptase. DNA ladder, 100 bp
Fig. 4. Effect of Von SV5 RNA transcription. (A) Schematic of mini-genome with mutant anti-genome promoter. Deletion of 6 nucleotides is indicated in the
mutant anti-genome promoter as a dashed line. This RNA has an intact SV5 leader sequence, which can be utilized by vRNAP for transcription, but it does not
have a functional trailer sequence, resulting in defect in RNA replication. Luc, luciferase gene. (B) Effect of V on luciferase expression in pMGmut-Rluc
system. Plasmids encoding NP, L, and pMGmut-Rluc were transfected into BSR T7 cells in 24-well plates in a set of 6 wells with increasing amounts of
pCAGGS-V (0, 0.008, 0.016, and 0.033 Ag/well) and luciferase activities were measured as described in Materials and methods. ‘‘No L’’ contains no
pCAGGS-V. pCAGGS-GFP was added to equalize amount of DNA used in transfection. Immunoblot against NP, P, and V were carried out as described in
Materials and methods. Size markers are indicated. Error bars are standard deviation of mean (SEM).
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Using the mini-genome system free of vaccinia virus, the
role of V in viral RNA synthesis has been examined in this
work. It was found that V inhibits both RNA replication and
transcription. The mechanism of V’s inhibitory effect on
SV5 replication is not known. The N-terminus of the V
protein interacts with soluble NP protein (Randall and
Bermingham, 1996). It is possible that the interaction
between V and NP plays a role in the process. There is an
RNA binding region in the shared N-terminus of V and P
protein (Lin et al., 1997a). Its role in viral RNA synthesis
remains unknown. Paramyxovirus Sendai virus encodes a V
protein that also binds to its NP protein (Curran et al., 1991;
Horikami et al., 1996). This interaction is important forSendai virus V protein’s ability to inhibit Sendai virus (SeV)
RNA replication (Curran et al., 1995). In addition to V, C
protein is involved in regulating virus RNA synthesis in
Sendai virus (Cadd et al., 1996; Curran et al., 1992; Grogan
and Moyer, 2001; Horikami et al., 1997; Tapparel et al.,
1997). Sendai virus lacking C protein has a severe defect in
virus growth (Koyama et al., 2003; Kurotani et al., 1998).
SV5 is not known to encode C proteins like Sendai virus. It
is possible that the V protein of SV5 functions like a
combination of both Vand C proteins of Sendai virus. While
a direct role of the V protein of SV5 in regulating RNA
replication seems plausible, it is possible that the V protein
acts indirectly. Because SV5 V causes degradation of
STAT1 protein (Chatziandreou et al., 2002; Young et al.,
Fig. 5. Inhibition of reporter gene expression by overexpression of the P protein. (A) Plasmids encoding NP, L, and pMG-Rluc were transfected into BSR T7
cells in 24-well plates with increasing amounts of pCAGGS-P (0.02, 0.05, 0.2, and 0.4 Ag P for 6 wells) and luciferase activities were measured as described in
Materials and methods. pCAGGS-GFP was added to equalize amount of DNA used in transfection. Error bars are standard deviation of mean (SEM). Amount
of P plasmid per well are indicated between the graph and Western blot. No L contains 0.1 Ag plasmid pCAGGS-P. Cell lysates from transfected cells described
above were subjected to SDS–PAGE and immunoblot using antibodies that recognize the P protein (Pk) as described in Materials and methods.
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replication through a host protein. It has been reported in
some negative strand RNA viruses that host factors are
involved in viral RNA synthesis (Bose et al., 2003; Moyer
et al., 1986). Interestingly, SV5 V inhibits both RNA
replication and transcription whereas the V protein of
Sendai virus only inhibits RNA replication. Although
overexpression of both V and P inhibited reporter gene
expression in the mini-genome system and Vand P share the
N-terminus, it is not clear whether the N-terminus is
required and sufficient for the inhibition and whether V
and P inhibit the expression in a similar manner or through a
different mechanism.
The significance of the inhibition of SV5 RNA synthesis
by V is not clear. It has been reported that mutant SV5
containing mutations in the shared region of V/P gene
coding region (recombinant CPI-virus) causes accelerated
viral gene expression (Wansley and Parks, 2002). It has
been shown that the recombinant CPI-virus induces
interferon-h (IFN-h) expression and causes increased cell
death (Wansley and Parks, 2002; Wansley et al., 2003). The
mechanisms of the increased expression of IFN-h in the
recombinant CPI-virus-infected cells and the cell death
induced by the recombinant CPI-virus are not clear. It was
proposed that cell death caused by the recombinant CPI-
virus infection might be triggered by increased expression
of viral proteins. It is thus possible that the V proteinprevents an early surge of viral RNA synthesis to avoid
activation of IFN-h and/or induction of apoptosis of the
infected cells.Materials and methods
Cells and plasmids
BSR T7 cells (Buchholz et al., 1999) were maintained in
DMEM containing 10% fetal calf serum (FCS), 10%
tryptose phosphatase broth, 400 Ag/ml G418, 100 I.U./ml
penicillin, and 100 Ag/ml streptomycin at 37 -C with 5%
CO2.
Plasmids pCAGGS-GFP, pMG-CAT, pMG-Rluc, and
pMGmut-RLuc were constructed using standard molecular
biology techniques. Sequence files are available on request.
Expression plasmids pCAGGS-NP, pCAGGS-L, pCAGGS-P,
and pCAGGS-V have been described before (Lin and Lamb,
2000; Waning et al., 2002).
Transfection, CAT, and luciferase assays
For CAT assays, cells in 6-well plates were 70–80%
confluent at the time of transfection. Plasmids pMG-CAT
and those encoding P, NP, L, or V were transfected into the
cells with Lipofectamine and Plus reagents (Invitrogen)
Y. Lin et al. / Virology 338 (2005) 270–280278according to manufacturer’s protocol. The amounts of
plasmids per well were as follows: pMG-CAT, 1 Ag;
pCAGGS-P, 0.6 Ag; pCAGGS-NP, 1.6 Ag; and pCAGGS-L,
2 Ag with or without pCAGGS-V at various amounts;
pCAGGS-GFP was used to normalize the amount of DNA
in each sample.
CAT assay was carried out as described before (He, 1996;
Neumann et al., 1987). Three days after transfection, cells
were washed in PBS once, then lysed by freezing and
thawing 3 times in 300 Al of 0.25 M Tris–Hcl, pH 8.0. For
each sample, 50 Al of lysate was added to the CAT reaction
mixture, which contained 0.25 ACi 14C-Acetyl-Coenzyme A
(50 mCi/mmol) (Amersham), 0.1 M Tris–Hcl, pH 8.0, and
1.25 mM chloramphenicol. Reaction was carried out at the
bottom of a glass scintillation vial and was immediately
overlaid with 5 ml of water-immiscible scintillation fluid
Econofluor (New England Nuclear). Radioactivity in
scintillation fluid was detected using a scintillation counter
(Beckman LS6000IC). Relative CAT activity is calculated
as cpm increase per minute while enzymatic reaction is still
in steady state.
As an alternative to CAT as a reporter gene, a Renilla
luciferase (Rluc) was used as a reporter gene in the mini-
genome system. To test the effects of expression levels of P
on mini-genome system, pMG-Rluc was used in place of
pMG-CAT. The BSR T7 cells in 24-well plates were
transfected as described above with plasmids encoding
NP, P, L, and pMG-Rluc. The amounts of plasmids per
sample were as follows: pMG-RLuc (0.22 Ag), pCAGGS-L
(0.22 Ag), pCAGGS-NP (0.17 Ag), and various amounts of
pCAGGS-P. pCAGGS-GFP was used to normalize the
amount of DNA per sample (approximately 0.75 Ag total
DNA per well). The cells were collected and luciferase
assays were carried out according to manufacture’s protocol
(Promega). Prior to luciferase assay, cells were washed in
PBS once, and 100 AL of the appropriate lysis buffer was
added. Cells were vigorously mixed for 15 min in order to
allow appropriate lysis to occur. 20 AL of lysate from each
well was then used in the subsequent luciferase experiment.
Luciferase readings were averaged for each sample and then
activity plotted graphically.
A Renilla luciferase (Rluc) gene in a plasmid containing
6-nucleotide deletion in the anti-genome promoter region
(pMGmut-Rluc) was used to examine whether V inhibits
viral RNA transcription. The BSR T7 cells in 24-well plates
were transfected as described above with plasmids encoding
NP, P, L, and pMGmut-Rluc with a plasmid expressing Vor
without. The amounts of plasmids per sample were as
follows: pMGmut-RLuc (0.22 Ag), pCAGGS-P (0.02 Ag),
pCAGGS-NP (0.17 Ag), pCAGGS-L (0.22 Ag), and
pCAGGS-V (0.008, 0.016, or 0.033 Ag). pCAGGS-GFP
was used to normalize the amount of DNA per sample
(approximately 0.75 Ag total DNA per well). The luciferase
assays were carried out as described above.
Due to variations in each DNA preparation, new DNA
preparations are tested for optimal amounts of DNA to useto generate to the most reporter gene activity in the mini-
genome system. Thus, amounts of plasmid DNA used in the
experiments are slightly different.
Immunoblot
An aliquot of the cell lysate for reporter gene assay was
saved and mixed with equal volume of 2 protein lysis
buffer (4% SDS, 40% glycerol, 3% dithiothreitol, 60 mM
Tris–Hcl pH 6.8, and a few grains of bromophenol blue)
(Paterson and Lamb, 1993). Samples were then subjected to
SDS–PAGE and transferred to a PVDF membrane. Immu-
noblot was performed as described before (Lin et al., 2003;
Sun et al., 2004).
Immunoprecipitation
BSR T7 cells in 6-well plates were mock infected or were
infected with rSV5 at am M.O.I. of 3 pfu/cell or were
transfected with plasmids expressing SV5 NP, P, and a CAT
reporter gene as described above. At 18 h post-infection, or
at 42 h post-transfection, cells were starved in DMEM-Cys-
Met-for 30 min and then labeled with 350 Al of 35S-Promix
(Amersham Life Science) (10 ACi/ml) for 3 h. The cells
were lysed in 0.3 M NaCl RIPA buffer and aliquots were
immunoprecipitated using anti-NP (NP214) (Randall et al.,
1987) and anti-V/P (Pk) antibody (Randall et al., 1987) as
described previously (Paterson and Lamb, 1993). Polypep-
tides were analyzed by SDS–PAGE using a 15% poly-
acrylamide gel.
RT-PCR
RT-PCR of SV5 L mRNA
Three days after transfection, total RNA was extracted
from transfected cells with RNeasy mini Kit with on-column
DNase digestion (Qiagen). Total RNA was then further
digested with RNase-free DNase (Novagen) at 37 -C for 3 h
to eliminate potential residual plasmid DNA contamination.
Samples were extracted with phenol, precipitated, and
resuspended in RNase-free H2O, followed by mRNA
extraction with Oligotex mRNA mini Kit (Qiagen). mRNA
concentration was determined by using a spectrophotometer.
100 ng of each mRNA sample was used for RT reaction
using oligos BH196 (5V-TGTAATGGACCTAAATCGT-
CAAGGTCG-3V), which anneals to the mRNA of L gene,
and h-Actin S (5V-TGCTGCGTGACATCAAAGAG-3V),
which anneals to h-Actin mRNA. One fifth of cDNA was
used for PCR reaction using oligo pair BH196 and BH313
(5V-GCCTACAGCGTAATTATGGCTGGGTCTCGGGA-
GATATTAC-3V) to amplify L, and oligo pair h-Actin S and
h-Actin AS (5V-TGGACAGTGAGGCCAGGATG-3V) to
amplify h-Actin. PCR was carried out at 94 -C for 1 min,
55 -C for 1 min, and 72 -C for 1 min for 30 cycles. 20 ng of
each mRNA sample was used for PCR under the same
conditions as negative controls.
Y. Lin et al. / Virology 338 (2005) 270–280 279RT-PCR of viral genome
Three days after transfection, cells were lysed with RIPA
buffer and immunoprecipitated with anti-NP antibody
(NP214) (Randall et al., 1987), followed by phenol and
chloroform extraction to purify NP-bound viral RNA. Yeast
RNA was used as carrier to facilitate RNA precipitation.
Samples were then digested with RNase-free DNase to
eliminate potential contamination of plasmid DNA. RNA
samples were extracted with phenol and precipitated again
and dissolved in 100 Al H2O. 10 Al was used for reverse
transcriptase (RT) (Invitrogen) reaction using SV5 trailer
primer (5V-AACCAAGATTAATCCTCTTC-3V), which
anneals to anti-genomic sense viral RNA. One fifth of
cDNAwas used for PCR amplification using oligo pair SV5
trailer and BH502 (5V-GTACTGCGATGAGTGGCAGGG-
CGG-3V), which anneals to CAT gene. PCR was carried out
at 94 -C for 1 min, 55 -C for 1 min, and 74 -C for 1 min for
15, 20, 25, and 30 cycles. 2 Ag of each RNA sample was
used for PCR for 30 cycles as controls for possible
contamination of plasmid DNA.Acknowledgments
We thank Dr. Robert A. Lamb for providing many
reagents used in the work. We appreciate other members of
Biao He’s lab for discussion and technical help. We are
grateful to Dr. Michael Teng for critically reading the
manuscript. The work was supported by a grant from the
National Institute of Allergy and Infectious Disease to B.H.
(R01 AI 051372) and a Scientist Development Grant from
the American Heart Association to B.H.References
Andrejeva, J., Childs, K.S., Young, D.F., Carlos, T.S., Stock, N.,
Goodbourn, S., Randall, R.E., 2004. The V proteins of paramyx-
oviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its
activation of the IFN-h promoter. Proc. Natl. Acad. Sci. U. S. A. 101
(49), 17264–17269.
Bose, S., Mathur, M., Bates, P., Joshi, N., Banerjee, A.K., 2003. Require-
ment for cyclophilin A for the replication of vesicular stomatitis virus
New Jersey serotype. J. Gen. Virol. 84 (Pt. 7), 1687–1699.
Buchholz, U.J., Finke, S., Conzelmann, K.K., 1999. Generation of bovine
respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not
essential for virus replication in tissue culture, and the human RSV
leader region acts as a functional BRSV genome promoter. J. Virol. 73,
251–259.
Cadd, T., Garcin, D., Tapparel, C., Itoh, M., Homma, M., Roux, L., Curran,
J., Kolakofsky, D., 1996. The Sendai paramyxovirus accessory C
proteins inhibit viral genome amplification in a promoter-specific
fashion. J. Virol. 70, 5067–5074.
Chatziandreou, N., Young, D., Andrejeva, J., Goodbourn, S., Randall, R.E.,
2002. Differences in interferon sensitivity and biological properties of
two related isolates of simian virus 5: a model for virus persistence.
Virology 293 (2), 234–242.
Cohn, M.L., Robinson, E.D., Thomas, D., Faerber, M., Carey, S., Sawyer,
R., Goswami, K.K., Johnson, A.H., Richert, J.R., 1996. T cell responsesto the paramyxovirus simian virus 5: studies in multiple sclerosis and
normal populations. Pathobiology 64 (3), 131–135.
Curran, J., Boeck, R., Kolakofsky, D., 1991. The Sendai virus P gene
expresses both an essential protein and an inhibitor of RNA synthesis by
shuffling modules via mRNA editing. EMBO J. 10, 3079–3085.
Curran, J., Marq, J.B., Kolakofsky, D., 1992. The Sendai virus non-
structural C proteins specifically inhibit viral mRNA synthesis.
Virology 189, 647–656.
Curran, J., Marq, J.B., Kolakofsky, D., 1995. An N-terminal domain of the
Sendai paramyxovirus P protein acts as a chaperone for the NP protein
during the nascent chain assembly step of genome replication. J. Virol.
69, 849–855.
Didcock, L., Young, D.F., Goodbourn, S., Randall, R.E., 1999. The V
protein of simian virus 5 inhibits interferon signalling by targeting
STAT1 for proteasome-mediated degradation. J. Virol. 73, 9928–9933.
Emerson, S.U., Yu, Y.-H., 1975. Both NS and L proteins are required for
in vitro RNA synthesis by vesicular stomatitis virus. J. Virol. 15,
1348–1356.
Evans, D.H., Stuart, D., McFadden, G., 1988. High levels of genetic
recombination among cotransfected plasmid DNAs in poxvirus-infected
mammalian cells. J. Virol. 62 (2), 367–375.
Grogan, C.C., Moyer, S.A., 2001. Sendai virus wild-type and mutant C
proteins show a direct correlation between L polymerase binding and
inhibition of viral RNA synthesis. Virology 288 (1), 96–108.
He, B., 1996. A gene expression system based on bacteriophage RNA
polymerase and characterization of bacteriophage T7 RNA polymerase.
Ph.D. Thesis. State University of New York, Brooklyn, NY.
He, B., Leser, G.P., Paterson, R.G., Lamb, R.A., 1998. The paramyxovirus
SV5 small hydrophobic (SH) protein is not essential for virus growth in
tissue culture cells. Virology 250, 30–40.
He, B., Lin, G.Y., Durbin, J.E., Durbin, R.K., Lamb, R.A., 2001. The
sh integral membrane protein of the paramyxovirus simian virus 5
is required to block apoptosis in mdbk cells. J. Virol. 75 (9),
4068–4079.
He, B., Paterson, R.G., Stock, N., Durbin, J.E., Durbin, R.K., Goodbourn,
S., Randall, R.E., Lamb, R.A., 2002. Recovery of paramyxovirus
simian virus 5 with a V protein lacking the conserved cysteine-rich
domain: the multifunctional V protein blocks both interferon-beta
induction and interferon signaling. Virology 303 (1), 15–32.
Horikami, S., Smallwood, S., Moyer, S.A., 1996. The Sendai virus V
protein interacts with the NP protein to regulate viral genome RNA
replication. Virology 222, 383–390.
Horikami, S.M., Hector, R.C., Smallwood, S., Moyer, S.A., 1997. The
Sendai virus C protein binds the L polymerase protein to inhibit viral
RNA synthesis. Virology 235, 261–270.
Hsiung, G.D., Chang, P.W., Cuadrado, R.R., Isacson, P., 1965. Studies of
parainfluenza viruses: III. Antibody responses of different animal
species after immunization. J. Immunol. 94, 67–73.
Jacques, J.P., Kolakofsky, D., 1991. Pseudo-templated transcription in
prokaryotic and eukaryotic organisms. Genes Dev. 5, 707–713.
Keller, M.A., Parks, G.D., 2003. Positive- and negative-acting signals
combine to determine differential RNA replication from the para-
myxovirus simian virus 5 genomic and antigenomic promoters.
Virology 306 (2), 347–358.
Koyama, A.H., Irie, H., Kato, A., Nagai, Y., Adachi, A., 2003. Virus
multiplication and induction of apoptosis by Sendai virus: role of the C
proteins. Microbes Infect. 5 (5), 373–378.
Kurotani, A., Kiyotani, K., Kato, A., Shioda, T., Sakai, Y., Mizumoto,
K., Yoshida, T., Nagai, Y., 1998. Sendai virus C proteins are
categorically nonessential gene products but silencing their expres-
sion severely impairs viral replication and pathogenesis. Genes Cells
3, 111–124.
Lamb, R.A., Kolakofsky, D., 2001. Paramyxoviridae: the viruses and their
replication. In: Knipe, D.M., Howley, P.M. (Eds.), Fields Virology, 4th
edR Lippincott, Williams and Wilkins, Philadelphia.
Lin, G.Y., Lamb, R.A., 2000. The paramyxovirus simian virus 5 V protein
slows progression of the cell cycle. J. Virol. 74 (19), 9152–9166.
Y. Lin et al. / Virology 338 (2005) 270–280280Lin, G., Paterson, R.G., Lamb, R.A., 1997a. The RNA binding region of the
paramyxovirus SV5 V and P proteins. Virology 238, 460–469.
Lin, G.Y., Paterson, R.G., Lamb, R.A., 1997b. The RNA binding region of
the paramyxovirus SV5 V and P proteins. Virology 238, 460–469.
Lin, Y., Bright, A.C., Rothermel, T.A., He, B., 2003. Induction of
apoptosis by paramyxovirus simian virus 5 lacking a small hydro-
phobic gene. J. Virol. 77 (6), 3371–3383.
Liston, P., Briedis, D.J., 1994. Measles virus V protein binds zinc. Virology
198, 399–404.
McCandlish, I.A., Thompson, H., Cornwell, H.J., Wright, N.G., 1978. A
study of dogs with kennel cough. Vet. Rec. 102 (14), 293–301.
Moyer, S.A., Baker, S.C., Lessard, J.L., 1986. Tubulin: a factor
necessary for the synthesis of both Sendai virus and vesicular
stomatitis virus RNAs. Proc. Natl. Acad. Sci. U. S. A. 83 (15),
5405–5409.
Neumann, J.R., Moreny, C.A., Russian, K., 1987. A novel rapid assay
for chloramphenicol acetyltransferase expression. BioTechniques 5,
444–447.
Paterson, R.G., Lamb, R.A., 1993. The molecular biology of influenza
viruses and paramyxoviruses. In: Davidson, A., Elliott, R.M. (Eds.),
Molecular Virology: A Practical Approach. IRL Oxford University
Press, Oxford, pp. 35–73.
Paterson, R.G., Harris, T.J.R., Lamb, R.A., 1984. Fusion protein of the
paramyxovirus simian virus 5: nucleotide sequence of mRNA predicts a
highly hydrophobic glycoprotein. Proc. Natl. Acad. Sci. U. S. A. 81,
6706–6710.
Paterson, R.G., Hiebert, S.W., Lamb, R.A., 1985. Expression at the cell
surface of biologically active fusion and hemagglutinin-neuraminidase
proteins of the paramyxovirus simian virus 5 from cloned cDNA. Proc.
Natl. Acad. Sci. U. S. A. 82, 7520–7524.
Paterson, R.G., Leser, G.P., Shaughnessy, M.A., Lamb, R.A., 1995. The
paramyxovirus SV5 V protein binds two atoms of zinc and is a
structural component of virions. Virology 208, 121–131.
Poole, E., He, B., Lamb, R.A., Randall, R.E., Goodbourn, S., 2002. The V
proteins of simian virus 5 and other paramyxoviruses inhibit induction
of interferon-beta. Virology 303 (1), 33–46.
Randall, R.E., Bermingham, A., 1996. NP:P and NP:V interactions of the
paramyxovirus simian virus 5 examined using a novel protein:protein
capture assay. Virology 224, 121–129.
Randall, R.E., Young, D.F., Goswami, K.K.A., Russell, W.C., 1987.
Isolation and characterization of monoclonal antibodies to simian virus5 and their use in revealing antigenic differences between human,
canine and simian isolates. J. Gen. Virol. 68, 2769–2780.
Schmitt, A.P., He, B., Lamb, R.A., 1999. Involvement of the cytoplasmic
domain of the hemagglutinin-neuraminidase protein in assembly of the
paramyxovirus simian virus 5. J. Virol. 73, 8703–8712.
Schmitt, A.P., Leser, G.P., Waning, D.L., Lamb, R.A., 2002. Require-
ments for budding of paramyxovirus simian virus 5 virus-like
particles. J. Virol. 76 (8), 3952–3964.
Steward, M., Samson, A.C.R., Errington, W., Emmerson, P.T., 1995. The
Newcastle disease virus V protein binds zinc. Arch. Virol. 140,
1321–1328.
Sun, M., Rothermel, T.A., Shuman, L., Aligo, J.A., Xu, S., Lin, Y., Lamb,
R.A., He, B., 2004. Conserved cysteine-rich domain of paramyxovirus
simian virus 5 V protein plays an important role in blocking apoptosis.
J. Virol. 78 (10), 5068–5078.
Tapparel, C., Hausmann, S., Pelet, T., Curran, J., Kolakofsky, D., Roux,
L., 1997. Inhibition of Sendai virus genome replication due to
promoter-increased selectivity: a possible role for the accessory C
proteins. J. Virol. 71, 9588–9599.
Thomas, S.M., Lamb, R.A., Paterson, R.G., 1988. Two mRNAs that differ
by two nontemplated nucleotides encode the amino coterminal proteins
P and V of the paramyxovirus SV5. Cell 54, 891–902.
Ulane, C.M., Horvath, C.M., 2002. Paramyxoviruses SV5 and HPIV2
assemble STAT protein ubiquitin ligase complexes from cellular
components. Virology 304 (2), 160–166.
Waning, D.L., Schmitt, A.P., Leser, G.P., Lamb, R.A., 2002. Roles for the
cytoplasmic tails of the fusion and hemagglutinin–neuraminidase
proteins in budding of the paramyxovirus simian virus 5. J. Virol. 76
(18), 9284–9297.
Wansley, E.K., Parks, G.D., 2002. Naturally occurring substitutions in the
p/v gene convert the noncytopathic paramyxovirus simian virus 5 into a
virus that induces alpha/beta interferon synthesis and cell death. J. Virol.
76 (20), 10109–10121.
Wansley, E.K., Grayson, J.M., Parks, G.D., 2003. Apoptosis induction and
interferon signaling but not IFN-beta promoter induction by an SV5 P/V
mutant are rescued by coinfection with wild-type SV5. Virology 316
(1), 41–54.
Young, D.F., Chatziandreou, N., He, B., Goodbourn, S., Lamb, R.A.,
Randall, R.E., 2001. Single amino acid substitution in the V protein of
simian virus 5 differentiates its ability to block interferon signaling in
human and murine cells. J. Virol. 75 (7), 3363–3370.
